Matthew R. Silver

Davis Polk advised the sales agent on the SEC-registered at-the-market offering by Atara Biotherapeutics, Inc. of its common stock for up to an aggregate amount of $100 million. Based in…

Davis Polk advised VF Corporation in connection with an SEC-registered debt shelf takedown of €500 million aggregate principal amount of its 0.250% senior notes due 2028 (the “2028 notes”)…

Davis Polk advised Cogna Educação S.A. in connection with its equity offering of 232,358,004 common shares for an aggregate amount of approximately R$2.6 billion (approximately $600 million…

Davis Polk advised Afya Limited on its SEC-registered follow-on offering of an aggregate of 12,426,740 Class A common shares, of which 3,019,928 shares were issued and sold by Afya and…

Davis Polk advised Zai Lab Limited in connection with its follow-on offering of approximately $300 million of American depositary shares, representing 5,500,000 ordinary shares by the…

Davis Polk advised the arrangers in connection with the establishment of the $6 billion global medium term note program of Prosus N.V. Davis Polk also the initial purchasers in connection…

Davis Polk advised Banco Santander Chile in connection with its Rule 144A and Regulation S offering of $750 million aggregate principal amount of its 2.700% senior fixed-rate notes due 2025…

Davis Polk advised Notre Dame Intermédica Participações S.A. in connection with the equity offering by Notre Dame Intermédica and Bain Capital, a shareholder of Notre Dame Intermédica, of…

Davis Polk advised Ranpak Holdings Corp. in connection with the $110 million SEC-registered offering of 16,923,077 shares of its Class A common stock, including 1,538,461 shares pursuant to…

Davis Polk advised the joint book-running managers and representatives of the several underwriters on the $64.3 million initial public offering by SiTime Corporation. SiTime’s common stock…